Labshake search
Citations for Stemcell Technologies :
51 - 100 of 531 citations for Calcium calmodulin Dependent 3' 5' Cyclic Nucleotide Phosphodiesterase 1C PDE1C Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2020Quote: ... containing 3 μM CHIR99021 (STEMCELL Technologies, Vancouver, Canada), 50 nM PI-103 from Bio-Techne Ltd ...
-
bioRxiv - Immunology 2019Quote: ... clone IV.3 (Stem Cell Technology Catalog; 60012); anti-human FcγRIIIa ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 3 μM CHIR-99021 (Stem Cell Technologies), and then for the 3 following days to 100 ng/ml Activin A alone ...
-
bioRxiv - Neuroscience 2022Quote: ... 3 µM CHIR99021 (STEMCELL Technologies, Vancouver, Canada, 72054), and 1 µM retinoic acid ...
-
bioRxiv - Immunology 2023Quote: ... Human Peripheral Blood Plasma (3%; Stem Cell Technologies), 3,3‘,5-Triiodo-L-thyronine (1 µM ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Canada), 500 μg.mL-1 bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 μM CHIR99021 (STEMCELL Technologies; Cat. No. 72054), 2 μM DMH1 (Sigma-Aldrich ...
-
bioRxiv - Microbiology 2024Quote: ... 5 µM CHIR99021 (StemCell technologies) and 1.25% V/V DMSO) ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Cancer Biology 2019Quote: ... IL-3/G-CSF–producing M2-10B4 and IL-3/KL-producing SI/SI murine fibroblasts in MyeloCult H5100 (StemCell Technologies) supplemented with hydrocortisone ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Cell Biology 2023Quote: ... final concentrations of either 3 µM CHIR99021 for definitive hematopoietic differentiation or 3 µM IWP2 (Selleckchem, S7085) and 1 ng/ml activin A (Stemcell Technologies, 78001) for primitive hematopoietic differentiation were added to the media for 30 hours ...
-
bioRxiv - Genomics 2019Quote: ... They were passaged using 1:3 Accutase (STEMCELL Technologies).
-
bioRxiv - Cell Biology 2021Quote: ... 1 μM PD03259010 and 3 μM CHIR99021 (STEMCELL Technologies) and 100 U/ml penicillin ...
-
bioRxiv - Developmental Biology 2022Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500 μg/mL bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml NT-3 (Stem Cell Technologies Cat # 78074), and Penicillin/Streptomycin (Thermo Fisher ...
-
bioRxiv - Cancer Biology 2021Quote: ... containing 3 mL Methocult GF H4230 (Stem Cell Technologies) and plated in triplicate in 35 mm gridded plates and incubating for 8-10 d.
-
bioRxiv - Immunology 2023Quote: ... and IL-3 (10 ng/mL; Stem Cell Technologies). After 5 days ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 µM Dorsomorphin (StemCell Technologies, 72102), 10 µM SB431542 (StemCell Technologies ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 5% FBS (StemCell Technology), L-glutamine (2 mM) ...
-
bioRxiv - Neuroscience 2019Quote: ... dispase (5 U/ml) (Stemcell Technologies), DNase I (2000 U/ml ...
-
bioRxiv - Pathology 2022Quote: ... and 5 µM SB431542 (StemCell Technologies). On Days8-14 ...
-
bioRxiv - Bioengineering 2023Quote: ... 5 µM Y27632 (72034; STEMCELL Technologies), 500 nM SB-202190 (S7067 ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 mg/mL dispase (STEMCELL Technologies), supplemented with 100 µg/mL DNase1 (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 unit/ml Dispase (Stemcell Technologies) and 0.05 mg/ml DNase I (Roche)) ...
-
bioRxiv - Bioengineering 2020Quote: MSCs at passages 1 or 3 were seeded in wells of a 12-well plate containing 3 ml Mesencult (Stem Cell Technologies, Vancouver, B.C.) each at 8.0×104 ...
-
bioRxiv - Developmental Biology 2021Quote: ... Passaging occurred every 3-4 days using ReLeSR (STEMCELL Technologies) and DPBS 1X (Gibco ...
-
bioRxiv - Neuroscience 2020Quote: ... and banked into 3-4 vials using mFreSR (Stemcell Technologies). Clearance of Sendai virus was confirmed using qPCR (Supplementary Table 4) ...
-
bioRxiv - Cancer Biology 2021Quote: ... in a 3:4 mixture of media (StemCell Technologies # 05620) and Matrigel (BD Bioscience CB-40324) ...
-
bioRxiv - Cell Biology 2020Quote: ... N2B27 medium was supplemented with 3 µM CHIR (STEMCELL Technologies) and 100 ng/mL Activin A (Biotechne) ...
-
bioRxiv - Cell Biology 2020Quote: ... Cells were passaged every 3 days using Relesr (STEMCELL Technologies) and supplemented with Rock Inhibitor Y-27632 (SelleckChem ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/ml IL-3 (STEMCELL Technologies; Cat. No. 78042) was directly added to the medium to support growth in the absence of an oncogene ...
-
bioRxiv - Microbiology 2022Quote: ... 20 ng/ml NT-3 (Stem Cell Technologies Cat # 78074), and Penicillin/Streptomycin cocktail ...
-
bioRxiv - Developmental Biology 2023Quote: ... 3 μM CHIR99021 (Chir) (Catalog no. 72054, Stem Cell Technologies), 1 μM PD0305901 (Catalog no ...
-
Pluripotent stem cell SOX9 and INS reporters facilitate differentiation into insulin-producing cellsbioRxiv - Developmental Biology 2021Quote: ... 5 ng/ml FGF7 (Stem Cell Technologies), 2 µM IWR-1 (Selleck Chemicals ...
-
bioRxiv - Cell Biology 2021Quote: ... suplemented with 5% FBS (StemCell Technology, 06200) and the same reagents and cytokine cocktail than the methylcellulose assays (full cytokine medium) ...
-
bioRxiv - Microbiology 2022Quote: ... 5 μM Y-27632 (Stem Cell Technologies), 1 μM A-83-01 (Tocris) ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 mM L-Glutamine (Stemcell Technologies; 07100), and 35 μg/ml L-Glutamic Acid (Sigma Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... supplemented with mTeSR1 5× Supplement (StemCell Technologies), ensuring the colony sizes were around 50-100 μm in diameter ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 µM FSK (STEMCELL Technologies, #100-0249) and 200 ng/ml NRG1 type III ...
-
bioRxiv - Bioengineering 2023Quote: ... containing 5 μM IWP4 (STEMCELL Technologies, 72552). An additional 48 hours later (on Day 5) ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5 μM SB-431542 (StemCell Technologies, 72234), and 1 μM LDN-193189 (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 mM L-glutamine (STEMCELL Technologies, 07100), and 35 μg ml-1 of L-glutamic acid (Sigma-Aldrich ...
-
bioRxiv - Genetics 2019Quote: ... 5×104/mL bone marrow and 5×105/mL spleen cells were cultured with MegaCult-C Kit (STEMCELL TECHNOLOGIES) for 9 days ...
-
bioRxiv - Cell Biology 2023Quote: ... 5% CO2) at a cell concentration of 5 × 105/mL in StemSpan Serum-Free Expansion Medium II (STEMCELL Technologies) supplemented with 100 ng/mL of human recombinant SCF ...
-
bioRxiv - Cell Biology 2023Quote: ... hiPSCs and hESCs were cultured in mTESR-Plus medium (StemCell Technologies at 5% O2, 5% CO2 and 37 °C). The cells were characterized based on expression of stemness markers (Oct4 ...
-
bioRxiv - Cancer Biology 2021Quote: ... in the same 3:4 mixture of media (StemCell Technologies #05620) and Matrigel (BD Bioscience CB-40324) ...
-
bioRxiv - Cell Biology 2021Quote: ... and IL-3 (1ng/mL first day only; Stemcell Technologies; Canada). Cell density was maintained between 0.7-2×106 cells/mL (CASY Model TCC ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant Fms-like tyrosine kinase-3 (Flt3, StemCell Technologies Cat#78009), Erythropoeitin (EPO ...
-
bioRxiv - Immunology 2020Quote: ... Following enumeration using 3% acetic acid with methylene blue (StemCell Technologies), splenocytes were resuspended in phosphate-buffered saline and forty to sixty million cells were injected either intraperitoneally or intravenously (via retro-orbital injection under isoflurane anesthesia ...